{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:31:53Z","timestamp":1790962313502,"version":"4.1.0"},"reference-count":29,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,2]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine Australian General Practitioners\u2019 (GPs) confidence in initiating oral anticoagulants (OACs) for patients with atrial fibrillation (AF), and their practices for monitoring treatment adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional online survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>GPs practising in metropolitan, regional and rural\/remote locations in Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1765 Australian GPs recruited through professional GP networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>\n                      GPs\u2019 self-reported confidence initiating OACs; practices monitoring patient adherence and persistence; and perceived barriers to adherence. Demographic data including clinical experience and geographic location were collected. \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      analyses were used to examine associations between the key outcome variables and GP location and clinical experience.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1765 respondents, 83.1% had practised for &gt;10 years and 27.6% worked in regional or rural\/remote areas. Overall, only 50.2% reported high confidence initiating OACs in patients with CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VA score \u22652 (a cumulative stroke risk score with a score of 1 for: congestive heart failure, hypertension, diabetes, vascular disease and age 65-74 years and 2 for: stroke\/transient ischaemic attack, age \u2265 75 years). Unsurprisingly, confidence was higher among GPs with &gt;10 years experience (51.5%) compared with 5\u201310 years (44.9%) and &lt;5 years (43.2%) (p&lt;0.01). Confidence was highest in rural\/remote areas (73.2%) compared with regional (56.4%) and metropolitan areas (46.0%) (p&lt;0.01). More GPs reported greater confidence initiating non-vitamin K antagonist oral anticoagulants (NOACs) (49.5%) than warfarin (6.2%) (p&lt;0.01). Regional and rural\/remote GPs, and those who had practised longer, were more likely to be confident with both NOACs and warfarin, while less experienced and metropolitan GPs showed stronger preference for NOACs. Only 76% reported monitoring adherence\/persistence to OAC therapy. Reported barriers to patient adherence and persistence included low health literacy, medication concerns, cognitive impairment and lack of awareness of stroke risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Only half of GPs reported high confidence initiating OAC treatment, and approximately a quarter do not routinely monitor medication adherence or persistence. Targeted strategies to improve confidence and align practices with guideline recommendations are required. Appropriate education should be developed targeting the specific issues underlying lack of confidence in initiating OAC and the practice of referring newly diagnosed patients to cardiology. Further research into implementing systems for monitoring and improving adherence and persistence would be worthwhile in the context of these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-112305","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:40:34Z","timestamp":1776271234000},"page":"e112305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["General practitioner confidence and practices in oral anticoagulant use for atrial fibrillation in Australia: findings from a cross-sectional study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8965-0402","authenticated-orcid":false,"given":"Omar","family":"Hamed","sequence":"first","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Wright","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-0336","authenticated-orcid":false,"given":"Katrina","family":"Giskes","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"},{"name":"Department of General Practice and Primary Care Research, School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lowres","sequence":"additional","affiliation":[{"name":"Heart Rhythm and Stroke Prevention, Heart Research Institute, Newtown, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-7277","authenticated-orcid":false,"given":"Jessica","family":"Orchard","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-2911","authenticated-orcid":false,"given":"Ben","family":"Freedman","sequence":"additional","affiliation":[{"name":"Heart Rhythm and Stroke Prevention, Heart Research Institute, Newtown, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-7728","authenticated-orcid":false,"given":"Charlotte Mary","family":"Hespe","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"},{"name":"Department of General Practice and Primary Care Research, School of Medicine, The University of Notre Dame Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026041509401544000_16.4.e112305.1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.STR.15.3.441","article-title":"Atrial fibrillation, TIAs and completed strokes","volume":"15","author":"Harrison","year":"1984","journal-title":"Stroke"},{"key":"2026041509401544000_16.4.e112305.2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006070"},{"key":"2026041509401544000_16.4.e112305.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.2.392"},{"key":"2026041509401544000_16.4.e112305.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.10.1765"},{"key":"2026041509401544000_16.4.e112305.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.10.1760"},{"key":"2026041509401544000_16.4.e112305.6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/mja18.00646","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"209","author":"Brieger","year":"2018","journal-title":"Med J Aust"},{"key":"2026041509401544000_16.4.e112305.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.12.013"},{"key":"2026041509401544000_16.4.e112305.8","unstructured":"The Royal Australian College of General Practitioners (RACGP) . General Practice: Health of the Nation 2023. East Melbourne RACGP; 2023."},{"key":"2026041509401544000_16.4.e112305.9","unstructured":"National Heart Foundation of Australia (NHFA) & Cardiac Society of Australia and New Zealand (CSANZ) . Australian clinical guidelines for the diagnosis and management of atrial fibrillation. 2018. Available: https:\/\/www.heartfoundation.org.au\/Bundles\/Your-heart\/Conditions\/Atrial-Fibrillation-for-Professionals"},{"key":"2026041509401544000_16.4.e112305.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2026041509401544000_16.4.e112305.11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.586370","article-title":"Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation","volume":"12","author":"Bezabhe","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026041509401544000_16.4.e112305.12","article-title":"Time trends in stroke risk management among high-risk patients with non-valvular atrial fibrillation in Australia between 2011-2019","volume":"53","author":"Giskes","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026041509401544000_16.4.e112305.13","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1093\/eurheartj\/ehy487","article-title":"Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?","volume":"39","author":"Freedman","year":"2018","journal-title":"Eur Heart J"},{"key":"2026041509401544000_16.4.e112305.14","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-04-0350"},{"key":"2026041509401544000_16.4.e112305.15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5603\/KP.2018.0180","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"76","author":"Steffel","year":"2018","journal-title":"Kardiol Pol"},{"key":"2026041509401544000_16.4.e112305.16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4070\/kcj.2019.0234","article-title":"Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal","volume":"49","author":"Lowres","year":"2019","journal-title":"Korean Circ J"},{"key":"2026041509401544000_16.4.e112305.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000534596","article-title":"Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation and Previous Stroke: A Systematic Review and Meta-Analysis","volume":"58","author":"Shi","year":"2024","journal-title":"Neuroepidemiology"},{"key":"2026041509401544000_16.4.e112305.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011471","article-title":"Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care","volume":"6","author":"Johnson","year":"2016","journal-title":"BMJ Open"},{"key":"2026041509401544000_16.4.e112305.19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00228-018-2540-3","article-title":"Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation","volume":"74","author":"Kjerpeseth","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"2026041509401544000_16.4.e112305.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-021-01590-x","article-title":"Patients\u2019 and clinicians\u2019 perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis","volume":"22","author":"Osasu","year":"2021","journal-title":"BMC Fam Pract"},{"key":"2026041509401544000_16.4.e112305.21","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2021.0226","article-title":"Use of direct oral anticoagulants in primary care: a qualitative study integrating patient and practitioner perspectives","volume":"6","author":"Osasu","year":"2022","journal-title":"BJGP Open"},{"key":"2026041509401544000_16.4.e112305.22","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.3390\/ijerph16245126","article-title":"Challenges in Managing Acute Cardiovascular Diseases and Follow Up Care in Rural Areas: A Narrative Review","volume":"16","author":"Thompson","year":"2019","journal-title":"IJERPH"},{"key":"2026041509401544000_16.4.e112305.23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ajr.12914","article-title":"Prevalence of atrial fibrillation in a regional Victoria setting, findings from the crossroads studies (2001-2003 and 2016-2018)","volume":"31","author":"Glenister","year":"2023","journal-title":"Aust J Rural Health"},{"key":"2026041509401544000_16.4.e112305.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018905","article-title":"Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry","volume":"8","author":"Apenteng","year":"2018","journal-title":"BMJ Open"},{"key":"2026041509401544000_16.4.e112305.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2295"},{"key":"2026041509401544000_16.4.e112305.26","unstructured":"Giskes K , Lowres N , Hespe C , et al . Stroke risk mitigation. Prescribing and monitoring anticoagulation in atrial fibrillation. Med Today 2024;12\u20138."},{"key":"2026041509401544000_16.4.e112305.27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0038-1676835","article-title":"Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review","volume":"119","author":"Pritchett","year":"2019","journal-title":"Thromb Haemost"},{"key":"2026041509401544000_16.4.e112305.28","doi-asserted-by":"crossref","unstructured":"Potpara T , Markovic BG , Grygier M , et al . Adherence to oral thromboprophylaxis in atrial fibrillation: an overview for clinicians. Europace 2025;27. doi:10.1093\/europace\/euaf250","DOI":"10.1093\/europace\/euaf250"},{"key":"2026041509401544000_16.4.e112305.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-112305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:40:37Z","timestamp":1776271237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-112305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-112305"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-112305","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}